<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2A32DD5F-F7BB-4A97-AD11-B00CA5D387A7"><gtr:id>2A32DD5F-F7BB-4A97-AD11-B00CA5D387A7</gtr:id><gtr:name>Dartmouth College</gtr:name><gtr:address><gtr:line1>Dartmouth College</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>College of Life Sciences</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2A32DD5F-F7BB-4A97-AD11-B00CA5D387A7"><gtr:id>2A32DD5F-F7BB-4A97-AD11-B00CA5D387A7</gtr:id><gtr:name>Dartmouth College</gtr:name><gtr:address><gtr:line1>Dartmouth College</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0CAD81AB-29BC-4CCE-9B12-C96A5706EE1D"><gtr:id>0CAD81AB-29BC-4CCE-9B12-C96A5706EE1D</gtr:id><gtr:firstName>Victoria</gtr:firstName><gtr:otherNames>Haigh</gtr:otherNames><gtr:surname>Cowling</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700240"><gtr:id>0FB10C25-7D2D-421C-8B9B-C37E5FCA66EC</gtr:id><gtr:title>The Mechanism of Myc Function in Cell Proliferation and Cancer</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700240</gtr:grantReference><gtr:abstractText>One in three people will have cancer during their lifetime. I investigate how cancer arises, because to treat it effectively, it is critical to know how we get the disease. A protein called Myc plays a prominent role in many human cancers. My research asks, How does Myc increase our risk of cancer? 
Over 20 years ago Myc was found to be a transcription factor, which means that it transcribes the DNA that codes for particular genes into messages. Those messages code for the synthesis of proteins that make up the cell. We want to know which genes Myc transcribes to drive cancer. Myc is actually a rather weak transcription factor, and I therefore started to search for other functions that Myc might have. This led me to discover that Myc regulates genes twice - not only does it increase the amount of message produced, it also increases the amount of protein produced from each message. 

 


This finding means that we have missed many of the significant genes that Myc activates. I want to find the novel Myc-activated genes and discover what they do in cancer cells. These genes will be new targets for cancer therapies.</gtr:abstractText><gtr:technicalSummary>The Mechanism of Myc Function in Cell Proliferation and Cancer
c-Myc expression is elevated in a significant proportion of cancers, and experimental Myc overexpression promotes tumour formation. Myc is also essential for cell proliferation. Despite the fact that Myc has a critical role in cell proliferation and transformation, we know little about the function of Myc during these processes. Myc is a transcription factor and it is via transactivation of target genes that Myc is presumed to function. Recently, I have found a novel biochemical function of Myc which is to promote mRNA cap methylation, a modification necessary for mRNA translation. To my knowledge, this is the first observation that a transcription factor can upregulate gene expression by increasing mRNA cap methylation. My research focus will be to biochemically characterise this novel Myc function and to investigate its role in Myc-induced cell proliferation and transformation. I will address:

1. What is the mechanism by which Myc promotes mRNA cap methylation?
2. What is the physiological significance of Myc-induced mRNA cap methylation?
3. Are Myc mutants found in cancers hyperactive for mRNA cap methylation? 

Mechanistic characterisation of this pathway will be carried out using co-immunoprecipitations, chromatin immunoprecipitations and by manipulating expression of pathway components using siRNA. Global identification of Myc-induced cap methylated mRNA will be carried out by purification of these mRNAs by immunoprecipitation and affinity chromatography followed by microarray analysis. This will reveal the extent of cap methylation in response to Myc and identify which mRNAs are methylated in response to Myc. My preliminary studies have demonstrated that Myc can upregulate two genes by simultaneous upregulation of transcription and mRNA cap methylation. The proposed microarray studies will reveal whether the majority of Myc transcriptional target genes are also subject to Myc-induced cap methylation.
I will investigate the significance of Myc-induced cap methylation in Myc-induced cell proliferation and transformation. Following identification of Myc-induced cap methylated mRNAs, I will investigate whether particular cellular pathways relevant to cell proliferation and transformation are targetted by this mechanism. I will select candidate mRNAs and determine whether they are required for Myc-induced cell proliferation and transformation in cell-based assays. I will also investigate whether Myc-induced cap methylation is hyperactivated by Myc mutants found in cancer.
The objective of this study is to better define the role of Myc in cancer with the long term goal of targetting Myc function in cancer therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2014-01-02</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-12-03</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1015974</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dartmouth College</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>PHARM/TOX Dartmouth</gtr:department><gtr:description>Sharing anti-methyl cap antibody</gtr:description><gtr:id>AF5C3509-14CD-443F-B1EB-ABCB72CB1D27</gtr:id><gtr:impact>We used reagent to get results and publish papers</gtr:impact><gtr:outcomeId>g1yhBdDu1xs-1</gtr:outcomeId><gtr:partnerContribution>Provided reagent</gtr:partnerContribution><gtr:piContribution>We used reagent to get results and publish papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Understanding Cancer Day 24/06/13</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D20C3FD5-BBEF-47F4-BEBC-9229F8016734</gtr:id><gtr:impact>Our objective with this event was to communicate our research to members of the public. We advertised our event through local cancer patient groups and cancer charities. 40 visitors attended including cancer survivors, current cancer patients, relatives of cancer patients, cancer charity workers and school children.

The day started with a general introduction to our unit and cancer research in our unit from Prof John Rouse. Prof Rouse, Dr Victoria Cowling and Dr Ian Ganley then explained their current research questions. This session was directly followed by a lively question and answer session, including discussion of our research and cancer research in general. During a refreshment break there was opportunity for more informal discussions with the Prof Rouse, Dr Cowling and Dr Ganley. At this time, lab tours were also conducted including demonstrating mass spectrometry, live cell imaging and the MRC-PPU research area. Dr Matthias Trost, Dr Thimo Kurz and Dr Yogesh Kaluthu assisted with the tours. A number of postdocs and PhD students were also involved throughout the day.

10 MRC staff took part in the day.
4 invitations were issued: 3 cancer patient groups and 1 cancer charity
40 visitors attended




Feedback from the visitors was positive.
100% of guests &amp;quot;completely enjoyed the event. 
There was equivalent interest in:
 - learning more about cancer research
 - meeting and chatting to scientists
 - finding out how medical research affects health
100% wanted to attend a similar event in the future.</gtr:impact><gtr:outcomeId>oMvniMKuhWU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Journal of Cell Science, &quot;One to watch&quot;</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>49A114CB-7D74-492F-B512-86932A0BC703</gtr:id><gtr:impact>I was interviewed on career matters; describing how I made choices, advice for new researchers, etc. The aim was to reach scientists and members of the general public.</gtr:impact><gtr:outcomeId>56a8bb17a86e53.61465146</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=OzW8hXLGgHg</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Research Fortnight magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>16F9E81F-CC5B-42C4-9B1A-EB9938550243</gtr:id><gtr:impact>Interview published in magazine describing how to go about getting awarded and EMBO Young Investigator Award

Communication with researchers how to help gain award</gtr:impact><gtr:outcomeId>XqXBMoGT2CD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Nusovus magazine (sent to lay public fundraisers for Tenovus Scotland))</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FC14D564-B661-4978-AB3A-B77F4F1BCDFD</gtr:id><gtr:impact>Newsletter sent to Tenovus Scotland fundraisers. This will help them raise more money.

Public fundraisers understood how their funds had been spent</gtr:impact><gtr:outcomeId>PGmoJJpvzWL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open doors day 2010</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>840788E6-35BE-41FE-8CA1-38500DE3556D</gtr:id><gtr:impact>100 members of public visited labs. They went on tours and looked at exhibits.

Too early to tell</gtr:impact><gtr:outcomeId>mwiYoqiR2Kz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit of school children</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BD95DBE7-E774-4E00-BADF-67206DC5243F</gtr:id><gtr:impact>3 visits of school children to my lab to learn about what a career in research entails

The schools keep sending pupils back</gtr:impact><gtr:outcomeId>eoVz7XttbXp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Prize Fellowship</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:id>E55E4BBF-6F7B-4173-A1A6-3071B2725810</gtr:id><gtr:outcomeId>Y1WwVsHKmwC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Tenovus Scotland</gtr:fundingOrg><gtr:id>40E33F70-526C-4F87-B899-4EE9E78CF0CE</gtr:id><gtr:outcomeId>XrbccwGnn6m0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124608</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK PhD Studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>45B38EBF-32CC-4250-9CCE-2B0F18CA9B25</gtr:id><gtr:outcomeId>F2283D4140B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Tenovus Scotland</gtr:fundingOrg><gtr:id>290992EB-B88A-4C98-AE7B-9D677337C42F</gtr:id><gtr:outcomeId>43303D46DB40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>polyclonal anti-RNMT antibody raised in sheep</gtr:description><gtr:id>AC37E5D5-9297-4189-BD94-DACF0B197ABC</gtr:id><gtr:impact>A commercial antibody was not available. This antibody was/is critical to our research</gtr:impact><gtr:outcomeId>BE8C1324F77</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>anti-RNMT antibody</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>polyclonal anti-RNGTT antibody raised in sheep</gtr:description><gtr:id>95C43667-1BA1-4559-A03A-47A4833EE5F7</gtr:id><gtr:impact>A commercial antibody was not available so this antibody opened new areas of research</gtr:impact><gtr:outcomeId>ngAjtqrk6P9</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>anti-RNGTT antibody</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>64F136B0-9CD0-4123-A7CD-E8AEA20F7963</gtr:id><gtr:title>DHX15 regulates CMTR1-dependent gene expression and cell proliferation</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abe02b1262f2f29ddc671f10e8d70a9c"><gtr:id>abe02b1262f2f29ddc671f10e8d70a9c</gtr:id><gtr:otherNames>Inesta-Vaquera F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a748b224c5904.88909586</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF78D499-2289-46CB-9018-A0CDC2F2E0A2</gtr:id><gtr:title>Regulation of mRNA cap methylation.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>11A41AE09D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFC3897C-252B-467A-98EC-7C7A2D98EB92</gtr:id><gtr:title>Mechanism of transcriptional activation by the Myc oncoproteins.</gtr:title><gtr:parentPublicationTitle>Seminars in cancer biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1044-579X</gtr:issn><gtr:outcomeId>FED874925E8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48DCF616-2C39-4BA9-B3DF-96D1F211BAC0</gtr:id><gtr:title>The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/513bf99cf9da07a229c70f87eb80c029"><gtr:id>513bf99cf9da07a229c70f87eb80c029</gtr:id><gtr:otherNames>Preston GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13404_24_24155966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA4AA18B-00EF-48A1-B386-6F0B19C32DF3</gtr:id><gtr:title>Turning the tables: Myc activates Wnt in breast cancer.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>ECD32725085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29B90384-E7C8-4984-B83B-CA2C3243ADAA</gtr:id><gtr:title>Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20a4b44c624114d42306871cd52fe101"><gtr:id>20a4b44c624114d42306871cd52fe101</gtr:id><gtr:otherNames>Cole MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>B186B7650D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37C5B320-5AD0-4D9C-91BC-F24221C308D3</gtr:id><gtr:title>E-cadherin repression contributes to c-Myc-induced epithelial cell transformation.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>8D19CD1B643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E7EBFB2-F3E1-4A82-9377-BA73ECEDF3C9</gtr:id><gtr:title>HATs off to capping: a new mechanism for Myc.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>FDC8F566DA3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A35F476-6FB2-498C-877C-039409ADB1E9</gtr:id><gtr:title>c-Myc deregulation induces mRNA capping enzyme dependency.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0f9c99c03aed86b37a418c3e9d455ba"><gtr:id>d0f9c99c03aed86b37a418c3e9d455ba</gtr:id><gtr:otherNames>Lombardi O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>5818674cead068.93053745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8BF1754-4F40-47CC-8F52-97739ADF585D</gtr:id><gtr:title>Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/513bf99cf9da07a229c70f87eb80c029"><gtr:id>513bf99cf9da07a229c70f87eb80c029</gtr:id><gtr:otherNames>Preston GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>56376b116c96b2.03335358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAC11270-2FF0-436E-9CD0-13A275C64353</gtr:id><gtr:title>A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3316c2493d21d02d8bbdf90b087890b0"><gtr:id>3316c2493d21d02d8bbdf90b087890b0</gtr:id><gtr:otherNames>Chandriani S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>536B9E370D4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7C75ABC-0449-4F33-A6C9-67F2D45D16EF</gtr:id><gtr:title>Transcription-independent functions of MYC: regulation of translation and DNA replication.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20a4b44c624114d42306871cd52fe101"><gtr:id>20a4b44c624114d42306871cd52fe101</gtr:id><gtr:otherNames>Cole MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>DBD94D15500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F337431-6FC9-4E0E-B02B-AE6D46F893C6</gtr:id><gtr:title>c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>5F7BF269674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4ED6E2F7-B612-4910-99D5-DC955AA566C4</gtr:id><gtr:title>mRNA Cap Methylation in Pluripotency and Differentiation.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7c67e82dbfa0379b4a786b94edc945c"><gtr:id>c7c67e82dbfa0379b4a786b94edc945c</gtr:id><gtr:otherNames>Grasso L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>57a34cce3c1ec4.57057949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16EFD937-8826-40EE-BBF3-48789FE31653</gtr:id><gtr:title>E2F1-dependent methyl cap formation requires RNA pol II phosphorylation.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f8cc929d4ded0da965509a0f8db29f1"><gtr:id>9f8cc929d4ded0da965509a0f8db29f1</gtr:id><gtr:otherNames>Aregger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_13404_24_22592528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>588200B9-2D86-4472-8F81-58DE9221A9AC</gtr:id><gtr:title>Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0751d8e349873ed23bed3477afefbabf"><gtr:id>0751d8e349873ed23bed3477afefbabf</gtr:id><gtr:otherNames>Varshney D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>57a34c6021be17.85512225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC6067BA-B587-45B8-9CE8-E28466F863DE</gtr:id><gtr:title>RAM function is dependent on Kap?2-mediated nuclear entry.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02bada412c48a5f8bcb238e62d6d3a1"><gtr:id>d02bada412c48a5f8bcb238e62d6d3a1</gtr:id><gtr:otherNames>Gonatopoulos-Pournatzis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_13404_24_24200467</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9530B419-25FC-43FE-A0DF-DDE3CA85F032</gtr:id><gtr:title>S-adenosyl homocysteine hydrolase is required for Myc-induced mRNA cap methylation, protein synthesis, and cell proliferation.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2371d313639b670392f75a649da7b228"><gtr:id>2371d313639b670392f75a649da7b228</gtr:id><gtr:otherNames>Fernandez-Sanchez ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>938CF6752B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>509C2135-7FAE-4A0D-9520-46E6E524AD62</gtr:id><gtr:title>An N-Myc truncation analogous to c-Myc-S induces cell proliferation independently of transactivation but dependent on Myc homology box II.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>DCED1F8538F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13CE48AD-8EC9-4E7A-B55D-329035DE82D8</gtr:id><gtr:title>Human cap methyltransferase (RNMT) N-terminal non-catalytic domain mediates recruitment to transcription initiation sites.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f8cc929d4ded0da965509a0f8db29f1"><gtr:id>9f8cc929d4ded0da965509a0f8db29f1</gtr:id><gtr:otherNames>Aregger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_13404_24_23863084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>908C9E40-5460-452D-83EC-2F346392D38E</gtr:id><gtr:title>A conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, and G2 arrest.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>8702CF709E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>333B6D4D-BD53-432C-AC7C-ED2363A61FE9</gtr:id><gtr:title>Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_13404_24_24013231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10995AD6-71FD-4861-A308-00EFB1E86AD9</gtr:id><gtr:title>Victoria Cowling.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d8ff532999ff3a7b0d763c9f6e4e4e"><gtr:id>35d8ff532999ff3a7b0d763c9f6e4e4e</gtr:id><gtr:otherNames>Cowling V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56376b113b5bd5.59095251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>794859C8-894D-4D9E-9A61-FDB10F2873D4</gtr:id><gtr:title>RAM/Fam103a1 is required for mRNA cap methylation.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02bada412c48a5f8bcb238e62d6d3a1"><gtr:id>d02bada412c48a5f8bcb238e62d6d3a1</gtr:id><gtr:otherNames>Gonatopoulos-Pournatzis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>Kpk1jeMpxCr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57BE72BF-14F5-48DB-88A3-1A5874497792</gtr:id><gtr:title>Enhanced mRNA cap methylation increases cyclin D1 expression and promotes cell transformation.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>7A107587706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36A26BC0-AD2F-4FE7-8E03-69FCD1E7D43E</gtr:id><gtr:title>Myc Regulation of mRNA Cap Methylation.</gtr:title><gtr:parentPublicationTitle>Genes &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1947-6019</gtr:issn><gtr:outcomeId>h2UY2a92DQx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAE1FBA5-EAC4-4C3C-9A20-5BEDE743831A</gtr:id><gtr:title>The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b41107878eb40cc161f6b916df094e5"><gtr:id>9b41107878eb40cc161f6b916df094e5</gtr:id><gtr:otherNames>Cowling VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>C4981BCD8EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EADD3AA-1B46-4778-A693-1C64A40A2562</gtr:id><gtr:title>SINE transcription by RNA polymerase III is suppressed by histone methylation but not by DNA methylation.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0751d8e349873ed23bed3477afefbabf"><gtr:id>0751d8e349873ed23bed3477afefbabf</gtr:id><gtr:otherNames>Varshney D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56376b11945757.06682867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>387891D0-A1DE-48C6-8BB2-E99B30ECDA30</gtr:id><gtr:title>Cap-binding complex (CBC).</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02bada412c48a5f8bcb238e62d6d3a1"><gtr:id>d02bada412c48a5f8bcb238e62d6d3a1</gtr:id><gtr:otherNames>Gonatopoulos-Pournatzis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>pm_13404_24_24438329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43D5C70E-7F31-4BD2-928B-ED7DCD57CFB9</gtr:id><gtr:title>CDK1-Cyclin B1 Activates RNMT, Coordinating mRNA Cap Methylation with G1 Phase Transcription.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f8cc929d4ded0da965509a0f8db29f1"><gtr:id>9f8cc929d4ded0da965509a0f8db29f1</gtr:id><gtr:otherNames>Aregger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56dd972d002af8.89097671</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700240</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>